Complications of injectable fillers and neurotoxins

Dermatologic Therapy

Volumn 24, Issue 6, 2011, Pages 524-536

  Cox, Sue Ellen ^a   Adigun, Chris G ^b  

^a Aesthetic Solutions   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

botulinum toxin; complications; injectables

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; APRACLONIDINE; BOTULINUM TOXIN; BOTULINUM TOXIN A; COLLAGEN; CORTICOSTEROID; FILLER; FLUOROURACIL; HYALURONIC ACID; HYALURONIDASE; HYDROXYAPATITE; NEUROTOXIN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLEPHRINE; POLY(METHYL METHACRYLATE); POLYLACTIC ACID; PREDNISONE; SOFT TISSUE FILLER; UNCLASSIFIED DRUG; VALACICLOVIR;

ADVERSE OUTCOME; ALLERGIC REACTION; ANGIONEUROTIC EDEMA; CHRONIC INFLAMMATION; CONTUSION; DELAYED HYPERSENSITIVITY; DRUG HYPERSENSITIVITY; DYSESTHESIA; DYSPHAGIA; ECCHYMOSIS; EDEMA; FACIAL NERVE PARALYSIS; FLU LIKE SYNDROME; FOREIGN BODY GRANULOMA; GRANULOMA; HEADACHE; HERPES SIMPLEX; HUMAN; HYPERPIGMENTATION; HYPERSENSITIVITY; HYPESTHESIA; HYPOPIGMENTATION; INFECTION; INJECTION SITE BLEEDING; INJECTION SITE CONTUSION; INJECTION SITE EDEMA; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE REACTION; INJECTION SITE SWELLING; LYMPHEDEMA; MIGRAINE; MUSCLE WEAKNESS; NECROSIS; PAIN; PTOSIS; PURPURA; REVIEW; RIGIDITY; SCAR FORMATION; SKIN NECROSIS; SWELLING; TELANGIECTASIA; VISUAL IMPAIRMENT;

BIOCOMPATIBLE MATERIALS; COSMETIC TECHNIQUES; HUMANS; INJECTIONS; NEUROTOXINS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84860170160     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2012.01455.x     Document Type: Review

References (38)

1. 2000/2008/2009 National Plastic Surgery Statistics, Cosmetic and Reconstructive Procedure Trends. American Society of Plastic Surgeons Plastic Surgery Educational Foundation. 444 E. Algonquin Rd., Arlington Heights, IL, 60005. 2010.
2. Krishtul A, Waldorf HA, Blitzer A,. Complications of cosmetic botulinum toxin therapy. In:, Carruthers A, ed. Botulinum toxin. Philadelphia, PA: W.B. Sanders, 2007: 111-121.
3. Hirsch R, Stier M,. Complications and their management in cosmetic dermatology. [Internet]. Dermatol Clin 2009: 27 (4): 507-520, vii. Accessed December 2010.
4. Alam M, Arndt KA, Dover JS,. Severe, intractable headache after injection with botulinum a exotoxin: report of 5 cases. [Internet]. J Am Acad Dermatol 2002: 46 (1): 62-65. Accessed December 2010. (Pubitemid 34073479)
5. Batra RS, Dover JS, Arndt KA,. Adverse event reporting for botulinum toxin type A. [Internet]. J Am Acad Dermatol 2005: 53 (6): 1080-1082. Accessed December 2010. (Pubitemid 41677338)
6. Carruthers JA, Lowe NJ, Menter MA, et al,. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. [Internet]. J Am Acad Dermatol 2002: 46 (6): 840-849. Accessed December 2010.
7. Narins RS, Brandt F, Leyden J, Lorenc ZP, Rubin M, Smith S,. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. [Internet]. Dermatol Surg 2003: 29 (6): 588-595. Accessed December 2010. (Pubitemid 36702442)
8. Cohen JL,. Understanding, avoiding, and managing dermal filler complications. [Internet]. Dermatol Surg 2008: 34 (Suppl. 1): S92-S99. Accessed December 2010. (Pubitemid 351792857)
9. Hirsch RJ, Stier M,. Complications of soft tissue augmentation. [Internet]. J Drugs Dermatol 2008: 7 (9): 841-845. Accessed December 2010.
10. Cox SE, Lawrence N,. Complications of soft tissue augmentation. In:, Carruthers J, Carruthers A, eds. Soft tissue augmentation. Philadelphia, PA: W.B. Saunders, 2008: 151-160.
11. Alijotas-Reig J, Garcia-Gimenez V,. Delayed immune-mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: clinical findings, long-term follow-up and review of the literature. [Internet]. J Eur Acad Dermatol Venereol 2008: 22 (2): 150-161. Accessed December 2010.
12. Lupton JR, Alster TS,. Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. [Internet]. Dermatol Surg 2000: 26 (2): 135-137. Accessed December 2010. (Pubitemid 30104340)
13. Friedman PM, Mafong EA, Kauvar ANB, Geronemus RG,. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. [Internet]. Dermatol Surg 2002: 28 (6): 491-494. Accessed December 2010. (Pubitemid 34686633)
14. Fitzgerald R, Graivier MH, Kane M, et al,. Nonsurgical modalities to treat the aging face. [Internet]. Aesthet Surg J/Am Soc Aesthetic Plast Surg 2010: 30 (Suppl. 3): 1S-5S. Accessed December 2010.
15. Jewel M,. Managing Adverse Events with Injectables. Webinar Nov. 2011.
16. Hirsch RJ, Cohen JL,. Surgical insights: challenge: correcting superficially placed hyaluronic acid. Skin Aging 2007: 15: 36-38.
17. Lowe NJ, Maxwell CA, Patnaik R,. Adverse reactions to dermal fillers: review. [Internet]. Dermatol Surg 2005: 31 (11 Pt 2): 1616-1625. Accessed December 2010.
18. Johl SS, Burgett RA,. Dermal filler agents: a practical review. [Internet]. Curr Opin Ophthalmol 2006: 17 (5): 471-479. Accessed December 2010. (Pubitemid 44319040)
19. Goldberg DJ,. Fillers in cosmetic dermatology. Abingdon, England: Informa UK Ltd, 2006.
20. Marmur M, Green L, Busso M,. Evaluation of pain with the use of lidocaine-mixed Radiesse for the treatment of nasolabial folds. Dermatol Surg 2010: 36 (3): 309-315.
21. Grunebaum L, Elsaie ML, Kaufman J,. Results of a six-month, double-blinded, split-face study to assess the efficacy and safety of calcium hydroxylapatite alone in subjects undergoing cutaneous correction of nasolabial fold wrinkles. Dermatol Surg 2010: 36: 760-765.
22. Jansen DA, Graivier MH,. Evaluation of a calcium hydroxylapatite-based implant (Radiesse) for facial soft-tissue augmentation. [Internet]. Plast Reconstr Surg 2006: 118 (3 Suppl.): 22S-30S; discussion 31S-33S. Accessed December 2010. (Pubitemid 44319087)
23. Goldberg DJ,. Breakthroughs in US dermal fillers for facial soft-tissue augmentation. [Internet]. J Cosmet Laser Ther 2009: 11 (4): 240-247. Accessed December 2010.
24. Butterwick K, Lowe NJ,. Injectable poly-L-lactic acid for cosmetic enhancement: learning from the European experience. [Internet]. J Am Acad Dermatol 2009: 61 (2): 281-293. Accessed December 2010.
25. Werschler P, the Cosmetic Study Investigator Group. Efficacy of injectable poly-L-lactic acid versus human collagen for the correction of nasolabial fold wrinkles. Presented at the American Society for Dermatologic Surgery; October 28, 2006; Palm Desert, Calif. Abstract CS359.
26. Beljaards RC, de Roos K-P, Bruins FG,. NewFill for skin augmentation: a new filler or failure? [Internet]. Dermatol Surg 2005: 31 (7 Pt 1): 772-776; discussion 776. Accessed December 2010. (Pubitemid 43110108)
27. Salles AG, Lotierzo PH, Gemperli R, et al,. Complications after polymethylmethacrylate injections: report of 32 cases. [Internet]. Plast Reconstr Surg 2008: 121 (5): 1811-1820. Accessed December 2010. (Pubitemid 351642742)
28. Lemperle G, Romano JJ, Busso M,. Soft tissue augmentation with artecoll: 10-year history, indications, techniques, and complications. [Internet]. Dermatol Surg 2003: 29 (6): 573-587; discussion 587. Accessed December 2010. (Pubitemid 36702440)
29. Cohen SR, Berner CF, Busso M, et al,. Five-year safety and efficacy of a novel polymethylmethacrylate aesthetic soft tissue filler for the correction of nasolabial folds. [Internet]. Dermatol Surg 2007: 33 (Suppl. 2): S222-S230. Accessed December 2010. (Pubitemid 350233468)
30. Gelfer A, Carruthers A, Carruthers J, Jang F, Bernstein SC,. The natural history of polymethylmethacrylate microspheres granulomas. [Internet]. Dermatol Surg 2007: 33 (5): 614-620. Accessed December 2010. (Pubitemid 46650373)
31. Carruthers A, Carruthers JDA,. Polymethylmethacrylate microspheres/collagen as a tissue augmenting agent: personal experience over 5 years. [Internet]. Dermatol Surg 2005: 31 (11 Pt 2): 1561-1564; discussion 1565. Accessed December 2010.
32. Sclafani AP, Fagien S,. Treatment of injectable soft tissue filler complications. [Internet]. Dermatol Surg 2009: 35 (Suppl. 2): 1672-1680. Accessed December 2010.
33. Lemperle G, Rullan PP, Gauthier-Hazan N,. Avoiding and treating dermal filler complications. [Internet]. Plast Reconstr Surg 2006: 118 (3 Suppl.): 92S-107S. Accessed December 2010. (Pubitemid 44319095)
34. Glaich AS, Cohen JL, Goldberg LH,. Injection necrosis of the glabella: protocol for prevention and treatment after use of dermal fillers. [Internet]. Dermatol Surg 2006: 32 (2): 276-281. Accessed December 2010.
35. Hirsch RJ, Cohen JL, Carruthers JDA,. Successful management of an unusual presentation of impending necrosis following a hyaluronic acid injection embolus and a proposed algorithm for management with hyaluronidase. [Internet]. Dermatol Surg 2007: 33 (3): 357-360. Accessed December 2010. (Pubitemid 46328237)
36. Schanz S, Schippert W, Ulmer A, Rassner G, Fierlbeck G,. Arterial embolization caused by injection of hyaluronic acid (Restylane). [Internet]. Br J Dermatol 2002: 146 (5): 928-929. Accessed December 2010. (Pubitemid 34539217)
37. Grunebaum LD, Bogdan Allemann I, Dayan S, Mandy S, Baumann L,. The risk of alar necrosis associated with dermal filler injection. [Internet]. Dermatol Surg 2009: 35 (Suppl. 2): 1635-1640. Accessed December 2010.
38. Narins RS, Jewell M, Rubin M, Cohen J, Strobos J,. Clinical conference: management of rare events following dermal fillers-focal necrosis and angry red bumps. [Internet]. Dermatol Surg 2006: 32 (3): 426-434. Accessed December 2010.